Literature DB >> 1617893

Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity.

L Altomonte1, A Zoli, L Mirone, P Scolieri, M Magaró.   

Abstract

Cytokines are potent immunoregulatory factors and may be directly involved in the disordered immunoregulation found in chronic rheumatic diseases. Interleukin-1b (IL-1b), Interleukin-2 (IL-2) and Tumour Necrosis Factor-a (TNF-a) have been implicated in the pathogenesis of rheumatoid arthritis (RA) as mediators of chronic inflammation. Serum levels of IL-1b and TNF-a measured by radioimmunoassay were significantly higher in patients with RA than in healthy controls of similar sex and age while serum levels of IL-2 were significantly lower in the same patients. Further IL-1b and TNF-a were significantly elevated in RA patients with active disease and IL-2 was significantly reduced when compared with patients with low active disease. Serum IL-1b and TNF-a appear to correlate with systemic inflammation, and systemic features of RA may result from dissemination of cytokines produced in the synovium. The role of IL-2 in RA remains controversial. Reduced levels of IL-2 may be an expression of a deficiency of T-cells to produce IL-2 in the active phases of RA or may be due to a possible absorption of IL-2 by lymphocyte receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617893     DOI: 10.1007/bf02207957

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis.

Authors:  M Rooney; J A Symons; G W Duff
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 2.  Role of cytokines in rheumatological inflammation.

Authors:  P Emery; D J Williamson; I R Mackay
Journal:  Concepts Immunopathol       Date:  1987

3.  Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  G Semenzato; L M Bambara; D Biasi; A Frigo; F Vinante; B Zuppini; L Trentin; C Feruglio; M Chilosi; G Pizzolo
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

4.  Cytokines and the chronic inflammation of rheumatic disease. III. Deficient interleukin-2 production in rheumatoid arthritis is not due to suppressor mechanisms.

Authors:  A M Nouri; G S Panayi
Journal:  J Rheumatol       Date:  1987-10       Impact factor: 4.666

Review 5.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

6.  Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Authors:  C Tetta; G Camussi; V Modena; C Di Vittorio; C Baglioni
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

7.  Synovial fluid concentration of five different cytokines in rheumatic diseases.

Authors:  C I Westacott; J T Whicher; I C Barnes; D Thompson; A J Swan; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

8.  Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  N Miyasaka; T Nakamura; I J Russell; N Talal
Journal:  Clin Immunol Immunopathol       Date:  1984-04

9.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  18 in total

1.  [Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation].

Authors:  S D Gadola
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

2.  Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities.

Authors:  A Kuryliszyn-Moskal
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity.

Authors:  L Mirone; L Altomonte; P D'Agostino; A Zoli; A Barini; M Magaro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Astaxanthin attenuates oxidative stress and inflammatory responses in complete Freund-adjuvant-induced arthritis in rats.

Authors:  Akshay Kumar; Navneet Dhaliwal; Jatinder Dhaliwal; Ravinder Naik Dharavath; Kanwaljit Chopra
Journal:  Pharmacol Rep       Date:  2019-12-19       Impact factor: 3.024

5.  Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay.

Authors:  G Egger; C Klemt; S Spendel; W Kaulfersch; H Kenzian
Journal:  Inflammation       Date:  1994-08       Impact factor: 4.092

6.  Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.

Authors:  Hae-Rim Kim; Kyoung-Woon Kim; So-Young Yoon; Sang-Hyon Kim; Sang-Heon Lee
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

7.  Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha.

Authors:  A Zoli; L Altomonte; R Caricchio; A Galossi; L Mirone; M P Ruffini; M Magaró
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

8.  Blood polymorphonuclear leukocyte migratory activities during rheumatoid arthritis.

Authors:  G Egger; F Aglas; F Rainer
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

9.  Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects.

Authors:  Zahid Ali; Bart Laurijssens; Thor Ostenfeld; Simon McHugh; Anastasia Stylianou; Paul Scott-Stevens; Louise Hosking; Odile Dewit; Jill C Richardson; Chao Chen
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

10.  Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women.

Authors:  Todd R Sponholtz; Xiaochun Zhang; Joao D T Fontes; James B Meigs; L Adrienne Cupples; Douglas P Kiel; Marian T Hannan; Robert R McLean
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-08       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.